These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 25074674)
1. B-type natriuretic peptide-guided therapy: a systematic review. Balion C; McKelvie R; Don-Wauchope AC; Santaguida PL; Oremus M; Keshavarz H; Hill SA; Booth RA; Ali U; Brown JA; Bustamam A; Sohel N; Raina P Heart Fail Rev; 2014 Aug; 19(4):553-64. PubMed ID: 25074674 [TBL] [Abstract][Full Text] [Related]
2. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Balion C; Santaguida PL; Hill S; Worster A; McQueen M; Oremus M; McKelvie R; Booker L; Fagbemi J; Reichert S; Raina P Evid Rep Technol Assess (Full Rep); 2006 Sep; (142):1-147. PubMed ID: 17764210 [TBL] [Abstract][Full Text] [Related]
3. A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods. Oremus M; McKelvie R; Don-Wauchope A; Santaguida PL; Ali U; Balion C; Hill S; Booth R; Brown JA; Bustamam A; Sohel N; Raina P Heart Fail Rev; 2014 Aug; 19(4):413-9. PubMed ID: 24953975 [TBL] [Abstract][Full Text] [Related]
4. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Santaguida PL; Don-Wauchope AC; Oremus M; McKelvie R; Ali U; Hill SA; Balion C; Booth RA; Brown JA; Bustamam A; Sohel N; Raina P Heart Fail Rev; 2014 Aug; 19(4):453-70. PubMed ID: 25062653 [TBL] [Abstract][Full Text] [Related]
5. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Oremus M; Don-Wauchope A; McKelvie R; Santaguida PL; Hill S; Balion C; Booth R; Brown JA; Ali U; Bustamam A; Sohel N; Raina P Heart Fail Rev; 2014 Aug; 19(4):471-505. PubMed ID: 24986335 [TBL] [Abstract][Full Text] [Related]
6. Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence. Hill SA; Booth RA; Santaguida PL; Don-Wauchope A; Brown JA; Oremus M; Ali U; Bustamam A; Sohel N; McKelvie R; Balion C; Raina P Heart Fail Rev; 2014 Aug; 19(4):421-38. PubMed ID: 24957908 [TBL] [Abstract][Full Text] [Related]
7. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923 [TBL] [Abstract][Full Text] [Related]
8. Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review. Santaguida PL; Don-Wauchope AC; Ali U; Oremus M; Brown JA; Bustamam A; Hill SA; Booth RA; Sohel N; McKelvie R; Balion C; Raina P Heart Fail Rev; 2014 Aug; 19(4):507-19. PubMed ID: 25052418 [TBL] [Abstract][Full Text] [Related]
9. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?). Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model. Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374 [TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials. Li P; Luo Y; Chen YM Heart Lung Circ; 2013 Oct; 22(10):852-60. PubMed ID: 23602555 [TBL] [Abstract][Full Text] [Related]
12. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP; Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis. Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664 [TBL] [Abstract][Full Text] [Related]
15. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF. Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. Clerico A; Fontana M; Ripoli A; Emdin M Adv Clin Chem; 2009; 48():163-79. PubMed ID: 19803419 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN; Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915 [TBL] [Abstract][Full Text] [Related]
18. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors. Suzuki S; Sugiyama S Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934 [TBL] [Abstract][Full Text] [Related]
19. Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis. Khan MS; Siddiqi TJ; Usman MS; Sreenivasan J; Fugar S; Riaz H; Murad MH; Mookadam F; Figueredo VM Int J Cardiol; 2018 Jul; 263():80-87. PubMed ID: 29685696 [TBL] [Abstract][Full Text] [Related]